Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical CystectomyPeter J Boström, Tuomas Mirtti, Bas van Rhijn, et al.
Translational Oncology|February 8, 2017
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerEkaterina Olkhov-Mitsel, Andrea J Savio, Ken J Kron, et al.
Epigenetics|August 10, 2012
Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancerEkaterina Olkhov-Mitsel, Theodorus Van der Kwast, Ken J Kron, et al.
BJU International|April 22, 2011
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohortGreg Trottier, Monique J Roobol, Nathan Lawrentschuk, et al.
European Radiology|April 27, 2018
Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trialSangeet Ghai, Nathan Perlis, Uri Lindner, et al.
European Urology|September 22, 2009
The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer gradingBas W G van Rhijn, Geert J L H van Leenders, Bert C M Ooms, et al.
European Urology|January 8, 2011
Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancerAntonio Finelli, Greg Trottier, Nathan Lawrentschuk, et al.
European Urology|June 9, 2004
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patientsAlexandre R Zlotta, Thierry Roumeguère, Vincent Ravery, et al.
Radiology|July 19, 2022
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive MenSangeet Ghai, Nathan Perlis, Chantal Atallah, et al.
Lancet Regional Health. Americas|October 3, 2025
Is it time for Canada to revisit its approach to prostate cancer screening?David-Dan Nguyen, Aisha Lofters, Christopher J D Wallis, et al.
Pageof 17